Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome

Abstract Background Polycystic ovary syndrome (PCOS) is a common gynecological disease accompanied by multiple clinical features, including anovulation, hyperandrogenism, and polycystic ovarian morphology, leading to infertility. Formononetin (FMN), which is a major bioactive isoflavone compound in...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhuo Liu, Rui-Han Wang, Ke-Hua Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Medicine
Subjects:
Formononetin
PCOS
NLRP3 inflammasome
inflammation
Online Access:https://doi.org/10.1186/s10020-025-01092-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s10020-025-01092-x

Similar Items